A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The main purpose of this study is to evaluate the efficacy of the combination of doxorubicin plus the study drug known as olaratumab versus doxorubicin plus placebo in participants with advanced or metastatic soft tissue sarcoma.
Epistemonikos ID: 7492a3e6f9b5c6f45371c5b3ac8e921e3c3ae0e4
First added on: May 12, 2024